Sunflower Pharmaceutical: Compound Polyethylene Glycol (3350) Electrolyte Oral Solution Obtains Drug Registration Certificate

K-LinePoet · 2026-02-28T21:32:12+00:00

Sunflower Pharmaceutical's subsidiary has obtained the registration certificate for Compound Polyethylene Glycol (3350) Electrolyte Oral Solution issued by the National Medical Products Administration. The medication is used to treat chronic constipation and fecal impaction.

K-LinePoet

2026-02-28 21:32:12

Abstract generation in progress

A sunflower pharmaceutical announcement: The subsidiary recently received a drug registration certificate issued by the National Medical Products Administration for the approval of Compound Polyethylene Glycol (3350) Electrolyte Oral Solution. The generic name of the drug is Compound Polyethylene Glycol (3350) Electrolyte Oral Solution, with main ingredients including PEG 3350, sodium chloride, potassium chloride, and sodium bicarbonate. The specification is 25ml per bag, and it is classified as a Category 3 chemical drug, prescription medication. The approval number is Guo Yao Zhun Zi H20263376. Indications include treatment of chronic constipation and fecal impaction. The listing license holder and manufacturer is Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.